MolecularWare, Inc. Names Senior Account Executive
CAMBRIDGE, Mass., May 1, 2002 -
MolecularWare’s Chief Executive Officer, Richard P. Kivel, announces the appointment of Michele Nathan Borek as Senior Account Executive. Ms. Nathan Borek will be responsible for the company’s national accounts in the life sciences market that its DigitalGenomeTM products serve.
"With an extensive background in the sale of instruments and software to pharmaceutical, biotechnology and research institutes, Ms. Nathan Borek significantly expands our company’s ability to demonstrate to researchers in genomics and proteomics the value of our flexible, time saving workflow management laboratory systems," stated Mr. Kivel.
Ms. Nathan Borek will be based in New Jersey and focus on East Coast sales. She has 14 years’ experience in the placement of instruments and software critical to the research process in the pharmaceutical and biotech arenas, most recently as Enterprise Bioinformatics Account Manager for Informax, Inc. She holds an undergraduate degree in biology and an MBA.
MolecularWare’s DigitalGenomeTM suite helps drug research companies save time and money by improving the tracking, archiving and quality of data generated from complex experiments performed around the world. The integration of workflow management and knowledge management made possible by MolecularWare’s AnalyzerDGTM, DesignerDGTM, and IntegratorDGTM products is expected to usher in a new era of molecular medicine, as vast amounts of information gleaned from genomics research is readily transformed into diagnostic strategies that predict and prevent disease.
MolecularWare customers include commercial and academic facilities around the world.
For more information, please contact:
Anne McCrory, Media Relations
Richard P. Kivel, CEO